Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups

Rebecca Powell Doherty

Postdoctoral Scientist

Dissecting the biological basis of HLA variation to susceptibility, disease progression, and response to therapies in Crohn’s Disease and Ulcerative Colitis

My work focuses on the development and progression of disease in individuals who have moderate to severe Crohn's Disease or Ulcerative Colitis. I investigate those with a known very strong but so far unexplained genetic predisposition to either severe colitis, or to developing antibodies which neutralise drugs known as anti-TNF biologics used in the treatment of inflammatory bowel disease in order to study the immunological mechanisms that underlie this genetic predisposition.

The genes involved are referred to as the HLA system, which are involved in regulating the immune response - these genes encode proteins that interact with antigens or fragments of antigens.  In one aspect of this work, we hope to be able to identify the specific antigens in the environment that trigger severe colitis, informing pathogenesis of disease.  In another aspect, we hope to identify the parts of the drugs which are responsible for causing patients to developing neutralising antibodies to biologics. This may allow a rational drug design of a non-immunogenic molecule.

Recent publications

More publications